论文部分内容阅读
本品系根据明代秦景明《症因脉治》记载的中医益气养阴固脱之名方《参冬饮》运用现代科学技术经剂型改革而成的中药注射剂,是中医急症用药研制的一项成果,在全国中医急症协作组组长会议上,作为首批推荐的药物之一,建议在全国推广使用。一、药理 1.参麦注射液对小白鼠、大白鼠及家兔的内毒素休克及失血性休克均有明显的保护作用,能减轻休克严重程度,降低休克死亡
This product is a traditional Chinese medicine injection based on the reform of dosage form of traditional Chinese medicine “Shen Dong Yin”, a famous Chinese medicine for Qi and Yangyin, which was recorded in Ming Dynasty Qin Jingming’s “Cause of Cause and Treatment”. It is a drug developed for the treatment of acute diseases of traditional Chinese medicine. As a result of the project, at the meeting of heads of the Chinese Medicine Emergency Cooperation Team, as one of the first batch of recommended drugs, it is recommended to promote the use throughout the country. First, pharmacology 1. Shenmai injection on mice, rats and rabbits endotoxin shock and hemorrhagic shock have significant protection, can reduce the severity of shock, reduce shock death